Trial Profile
A long-term efficacy study of Ustekinumab in patients previously treated with TNF inhibitors and with psoriasis and psoriatic Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- 23 Aug 2016 New trial record